Search - Archive ouverte HAL Access content directly

Filter your results

3 Results
authFullName_s : Matthew Hellmann

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.

Matthew Hellmann , Luis Paz-Ares , Reyes Bernabe Caro , Bogdan Zurawski , Sang-We Kim et al.
New England Journal of Medicine, 2019, 381 (21), pp.2020-2031. ⟨10.1056/NEJMoa1910231⟩
Journal articles hal-02528435v1

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

Kyung Hae Jung , Patricia Lorusso , Howard Burris , Michael Gordon , Yung-Jue Bang et al.
Clinical Cancer Research, 2019, 25 (11), pp.3220-3228. ⟨10.1158/1078-0432.CCR-18-2740⟩
Journal articles hal-02528511v1

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Bertrand Routy , Emmanuelle Le Chatelier , Lisa Derosa , Connie Duong , Maryam Tidjani Alou et al.
Science, 2018, 359 (6371), pp.91-97. ⟨10.1126/science.aan3706⟩
Journal articles hal-02126484v1